Skip to content

Platelet Rich Plasma (PRP) as a Treatment for Knee Osteoarthritis PRP as a Treatment for Knee Osteoarthritis

Platelet Rich Plasma (PRP) as a Treatment for Knee Osteoarthritis - A Randomized-Double-Blind Trial

Status
UNKNOWN
Phases
Phase 2Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01270412
Acronym
PRP
Enrollment
100
Registered
2011-01-05
Start date
2011-09-30
Completion date
2013-12-31
Last updated
2011-07-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis of the Knee

Keywords

Osteoarthritis, PRP, PRGF, Hyaluronic acid

Brief summary

Autologous platelet-secreted growth factors (GFs) may have therapeutic effects in osteoarthritis (OA) capsular joints via multiple mechanisms. The aim is to examine the effect of a platelet-derived preparation rich in growth factors (PRGFs) in OA of the knee.

Detailed description

Autologous platelet-secreted growth factors (GFs) may have therapeutic effects in osteoarthritis (OA) capsular joints via multiple mechanisms. The investigators aim is to examine the effect of a platelet-derived preparation rich in growth factors(PRGFs) in OA of the knee, using parameters of pain, function, quality of life and safety.

Interventions

BIOLOGICALPlatelet Rich Plasma (Preparation Rich in Growth Factors)

intra articular injection 6ml

DRUGHyaluronic acid

Intra articular injections: 20 mg / 2 ml

Sponsors

Meir Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
40 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* age 40-75 years old * diagnosed Oa of the knee more then 1 year * no knee deformation

Exclusion criteria

* mental of physical disabilities * pregnancy * deformities of the knee

Design outcomes

Primary

MeasureTime frameDescription
Improvement in pain, function, quality of life and activity level in knee osteoarthritis1 -2 yearsImprovement in pain, function, quality of life, activity level - using scores adapted to measure these parameters in knee osteoarthritis.

Countries

Israel

Contacts

Primary ContactLior Laver, MD
laver17@gmail.com+972-50-8464466

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026